Science & Medicine

Podcast: No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

Name: Radio and Podcast
Availability: InStock

CampaignCheckup by Medical Marketing & Media

Jul 27, 2016Science & Medicine

Marc Iskowitz, MM&M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin, VP at TrialCard, in this sponsored podcast.

Podcast: No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

Related Episodes

Podcast: Adherence: Leveraging Data to Enhance Your Brand's Ability to Reach Target Patients

Podcast: "I Need to Transition My HUB Program. What Do I Do Next?" Here are Best Practices for a Successful HUB Program Transition

Podcast: What Does Success Look Like in Patient Affordability?

Podcast: AstraZeneca's "Take it from a fish"

Podcast: Pfizer's and Bristol-Myers Squibb's "Cardiac Resuscitation"